Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' VALLERON AJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Valleron, AJ; Boelle, PY; Will, R; Cesbron, JY
      Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom

      SCIENCE
    2. Valleron, AJ
      Evidence and causality assessment in environmental epidemiology: methodological aspects.

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    3. Valleron, AJ
      Roles of mathematical modelling in epidemiology

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    4. Deuffic, S; Poynard, T; Valleron, AJ
      Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe

      JOURNAL OF VIRAL HEPATITIS
    5. Carrat, F; Tachet, A; Rouzioux, C; Housset, B; Valleron, AJ
      Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France

      CLINICAL INFECTIOUS DISEASES
    6. Cohen, CH; Valleron, AJ
      When did bovine spongiform encephalopathy (BSE) start? Implications on theprediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic

      INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
    7. Deuffic, S; Buffat, L; Poynard, T; Valleron, AJ
      Modeling the hepatitis C virus epidemic in France

      HEPATOLOGY
    8. Yazdanpanah, Y; Boelle, PY; Carrat, F; Guiguet, M; Abiteboul, D; Valleron, AJ
      Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France

      JOURNAL OF HEPATOLOGY
    9. Chauvin, P; Valleron, AJ
      Persistence of susceptibility to measles in France despite routine immunization: A cohort analysis

      AMERICAN JOURNAL OF PUBLIC HEALTH
    10. Cohen, CH; Cesbron, JY; Valleron, AJ
      Cost-effectiveness of bovine spongiform encephalopathy screening

      VETERINARY RECORD
    11. ILG AGS; BIGNON J; VALLERON AJ
      ESTIMATION OF THE PAST AND FUTURE BURDEN OF MORTALITY FROM MESOTHELIOMA IN FRANCE

      Occupational and environmental medicine
    12. YAZDANPANAH Y; BOELLE PY; CARRAT F; GUIGUET M; VALLERON AJ
      RISK OF HEPATITIS-C VIRUS (HCV) TRANSMISSION TO A SURGEON FROM AN INFECTED PATIENT - ESTIMATES IN FRANCE BASED ON A MODEL

      Infection control and hospital epidemiology
    13. KARMOCHKINE M; CARRAT F; VALLERON AJ; RAGUIN G
      MODES OF HEPATITIS-C VIRUS TRANSMISSION

      La Presse medicale
    14. Valleron, AJ
      Claude Chastang, professor of biostatistics - Necrology

      PRESSE MEDICALE
    15. CARRAT F; GUEZELOT M; CHAUVIN P; IMBERT JC; VALLERON AJ; LEBAS J
      ACCESS TO HEALTH-INSURANCE COVERAGE OF UNINSURED PATIENTS ATTENDING AN OUTPATIENT-CLINIC - A HISTORICAL PROSPECTIVE-STUDY IN PARIS, FRANCE

      Revue d'epidemiologie et de sante publique
    16. CARRAT F; TACHET A; ROUZIOUX C; HOUSSET B; VALLERON AJ
      FIELD INVESTIGATION OF INFLUENZA VACCINE EFFECTIVENESS ON MORBIDITY

      Vaccine
    17. CHAUVIN P; VALLERON AJ
      PARTICIPATION OF FRENCH GENERAL-PRACTITIONERS IN PUBLIC-HEALTH SURVEILLANCE - A MULTIDISCIPLINARY APPROACH

      Journal of epidemiology and community health
    18. CARRAT F; FLAHAULT A; BOUSSARD E; FARRAN N; DANGOUMAU L; VALLERON AJ
      SURVEILLANCE OF INFLUENZA-LIKE ILLNESS IN FRANCE - THE EXAMPLE OF THE1995 1996 EPIDEMIC/

      Journal of epidemiology and community health
    19. DEUFFIC S; POYNARD T; BUFFAT L; VALLERON AJ
      TRENDS IN PRIMARY LIVER-CANCER

      Lancet
    20. FLAHAULT A; DIASFERRAO V; CHABERTY P; ESTEVES K; VALLERON AJ; LAVANCHY D
      FLUNET AS A TOOL FOR GLOBAL MONITORING OF INFLUENZA ON THE WEB

      JAMA, the journal of the American Medical Association
    21. BOELLE PY; VIBERT JF; GARNERIN P; VALLERON AJ
      SHARE - A TOOL TO ANALYZE AND ASSESS STRATEGIES IN HEALTH-CARE ORGANIZATION MANAGEMENT

      Computers and biomedical research
    22. CARRAT F; TACHET A; HOUSSET B; VALLERON AJ; ROUZIOUX C
      INFLUENZA AND INFLUENZA-LIKE ILLNESS IN GENERAL-PRACTICE - DRAWING LESSONS FOR SURVEILLANCE FROM A PILOT-STUDY IN PARIS, PRANCE

      British journal of general practice
    23. FLAHAULT A; BOUSSARD E; VIBERT JF; VALLERON AJ
      SENTIWEB REMAINS EFFICIENT TOOL FOR NATIONWIDE SURVEILLANCE OF DISEASE

      BMJ. British medical journal
    24. CHAUVIN P; MORTIER E; CARRAT F; IMBERT JC; VALLERON AJ; LEBAS J
      A NEW OUTPATIENT CARE FACILITY FOR HIV-INFECTED DESTITUTE POPULATIONSIN PARIS, FRANCE

      AIDS care
    25. CHAUVIN P; VALLERON AJ
      MONITORING THE COMPLIANCE OF SENTINEL GENERAL-PRACTITIONERS IN PUBLIC-HEALTH SURVEILLANCE - WHICH GPS PERSEVERE

      International journal of epidemiology
    26. DEUFFIC S; BUFFAT L; POYNARD T; VALLERON AJ
      MODELING OF THE NATURAL-HISTORY OF HCV INFECTION PREDICTS A DRAMATIC INCREASE IN THE HCC MORTALITY BURDEN

      Hepatology
    27. SEBILLE V; VALLERON AJ
      A COMPUTER-SIMULATION MODEL FOR THE SPREAD OF NOSOCOMIAL INFECTIONS CAUSED BY MULTIDRUG-RESISTANT PATHOGENS

      Computers and biomedical research
    28. BOELLE PY; GARNERIN P; HERGON E; ROUGER P; VALLERON AJ
      QUALITY ASSURANCE AND PREVENTION OF IMMUN O-HEMOLYTIC INCIDENTS IN BLOOD-TRANSFUSION

      Transfusion clinique et biologique
    29. BOUSSARD E; FLAHAULT A; VIBERT JF; VALLERON AJ
      SENTIWEB - FRENCH COMMUNICABLE DISEASE SURVEILLANCE ON THE WORLD-WIDE-WEB

      BMJ. British medical journal
    30. CHAUVIN P; PETITPRETZ P; BRAI A; FOURNIER M; FLAHAULT A; NEUKIRCH F; VALLERON AJ
      MANAGEMENT OF EPISODES OF BRONCHIAL INFEC TIONS IN GENERAL MEDICINE

      Revue des maladies respiratoires
    31. CHAUVIN P; MORTIER E; VALLERON AJ; LEBAS J
      OUTPATIENTS CARE OF HIV-1-INFECTED DESTITUTE PEOPLE - A STUDY IN PARIS, FRANCE

      Lancet
    32. LAZARD T; RETEL O; GUIDET B; MAURY E; VALLERON AJ; OFFENSTADT G
      AIDS IN A MEDICAL INTENSIVE-CARE UNIT - IMMEDIATE PROGNOSIS AND LONG-TERM SURVIVAL

      JAMA, the journal of the American Medical Association
    33. LEPONT F; COSTAGLIOLA D; ROUZIOUX C; VALLERON AJ
      TESTING FOR HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN - REPLY

      Transfusion
    34. LEPONT F; COSTAGLIOLA D; VALLERON AJ; ROUZIOUX C
      HOW MUCH WOULD THE SAFETY OF BLOOD-TRANSFUSION BE IMPROVED BY INCLUDING P24 ANTIGEN IN THE BATTERY OF TESTS

      Transfusion
    35. AYMARD M; AUTRET E; LEROY O; OLIVIER C; DANJOU C; PLETAN Y; ELHABIB R; REBIERE I; ESPIE J; ROUZIOUX JM; FRITZELL B; VALLERON AJ; HESSEL L
      EVALUATION METHODOLOGY OF VIRAL VACCINE

      Therapie
    36. BOELLE PY; GARNERIN P; VALLERON AJ
      A SEQUENTIAL PROCEDURE TO TEST THE PROGRESSIVE DECREASE OF RARE ADVERSE EVENTS

      Computers in biology and medicine
    37. CHAUVIN P; VALLERON AJ
      ATTITUDE OF FRENCH GENERAL-PRACTITIONERS TO THE PUBLIC-HEALTH SURVEILLANCE OF COMMUNICABLE DISEASES

      International journal of epidemiology
    38. LEPONT F; COSTAGLIOLA D; MASSARI V; VALLERON AJ
      ESTIMATION OF THE SIZE OF THE HIV AIDS EPIDEMIC DUE TO BLOOD-TRANSFUSION IN FRANCE/

      International journal of epidemiology
    39. CARRAT F; VALLERON AJ
      INFLUENZA MORTALITY AMONG THE ELDERLY IN FRANCE, 1980-90 - HOW MANY DEATHS MAY HAVE BEEN AVOIDED THROUGH VACCINATION

      Journal of epidemiology and community health
    40. FLAHAULT A; GARNERIN P; CHAUVIN P; FARRAN N; SAIDI Y; DIAZ C; TOUBIANA L; DRUCKER J; VALLERON AJ
      SENTINELLE TRACES OF AN EPIDEMIC OF ACUTE GASTROENTERITIS IN FRANCE

      Lancet
    41. LEPONT F; COSTAGLIOLA D; ROUZIOUX C; VALLERON AJ
      HOW MUCH WOULD THE SAFETY OF BLOOD-TRANSFUSION BE IMPROVED BY INCLUDING P24 ANTIGEN IN THE BATTERY OF TESTS

      Transfusion
    42. TOUBIANA L; VIBERT JF; GARNERIN P; VALLERON AJ
      SITIE - A HEALTH-CARE WORKSTATION INTEGRATION ARCHITECTURE FOR EPIDEMIOLOGISTS

      Computers and biomedical research
    43. ROUZIOUX C; COSTAGLIOLA D; BURGARD M; BLANCHE S; MAYAUX MJ; GRISCELLI C; VALLERON AJ; ALLEMON MC; ARMENGAUD D; BABINET JM; BALDE P; BENFADEL F; BENSADOUN R; BERTEROTIERE D; BODDAERT M; BOMPARD Y; BOTTO C; BRUNNER AM; CACAULT JA; CARLUSMONCOMBLE C; CIRARUVIGNERON N; COHEN C; COLINGORKI AM; COURPOTIN C; CRUMIERE C; DALLOT MC; DANDINE M; DECREPY A; DEBONS M; DEBRE M; DENAVIT MF; DEVIDAS A; DUMONTEL M; FIRTION G; FLOCH C; FRANCOUAL C; FURIOLI J; GANTZER A; GRANIER F; GUILLOT F; HELLER B; HURAUXRENDU C; LABRUNE P; LACHASSINE E; LACROIX A; LANZA M; LAJALLE H; LELORIER B; LEBLANC A; LEBRUN F; LEJEUNE C; MAMOU J; MAY A; MAZI F; MEYER A; MOUCHNINO G; NARCY P; NOSEDA G; PASCAL C; PAUTARD B; ROBIN M; RONZIER M; ROPERT JL; ROUSSET MC; SAILLANT A; SCART G; SEAUME H; SEGUY D; TALON P; TARDIEU M; TERRIS J; VALDES L; VEBER F; VEDRENNE J; VIAL M; VINAS A; VINCENT N; WIPFF P
      ESTIMATED TIMING OF MOTHER-TO-CHILD HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TRANSMISSION BY USE OF A MARKOV MODEL

      American journal of epidemiology
    44. VALLERON AJ; CHAUVIN P; FLAHAULT A; VIBERT JF
      ALERT SYSTEMS - PAST, PRESENT AND FUTURE

      Transfusion clinique et biologique
    45. ROUGER P; HERGON E; LEPENNEC PY; GARNERIN P; VALLERON AJ
      IMMUNOLOGICAL RISK IN BLOOD-TRANSFUSION A ND PUBLIC-HEALTH

      Transfusion clinique et biologique
    46. RAFLA M; IBRAHIM AS; VALLERON AJ; MARY JY
      A CLASSIFICATION AFTER RADICAL CYSTECTOMY OF PATIENTS WITH BLADDER-CANCER ASSOCIATED WITH SCHISTOSOMIASIS

      European journal of cancer
    47. GUIGUET M; LEPONT F; RETEL O; VALLERON AJ
      CHANGES IN HIV RISK BEHAVIOR AMONG FRENCH HETEROSEXUALS - PATTERNS OFSEXUAL MONOGAMY AND CONDOM USE BETWEEN 1988 AND 1991

      Journal of acquired immune deficiency syndromes
    48. CARRAT F; VALLERON AJ
      ANTI-FLU VACCINE - REVIEW OF THE LITERATU RE

      Revue des maladies respiratoires
    49. FLAHAULT A; DEGUEN S; VALLERON AJ
      A MATHEMATICAL-MODEL FOR THE EUROPEAN SPREAD OF INFLUENZA

      European journal of epidemiology
    50. MASSARI V; COSTAGLIOLA D; VALLERON AJ
      ESTIMATION OF THE NUMBER OF HIV-SEROPOSITIVE PATIENTS KNOWN TO GENERAL-PRACTITIONERS IN FRANCE

      AIDS
    51. RUDE N; COSTAGLIOLA D; VALLERON AJ
      PREVALENCE OF HIV-INFECTION IN FRANCE BEF ORE THE INTRODUCTION OF EARLY THERAPY - ESTIMATION BY BACKCALCULATION

      Revue d'epidemiologie et de sante publique
    52. RETEL O; COSTAGLIOLA D; VALLERON AJ
      ANALYSIS OF REPORTING DELAYS IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME CASES IN FRANCE

      Revue d'epidemiologie et de sante publique
    53. MARYKRAUSE M; MARY JY; VALLERON AJ
      CONDITIONS OF VALIDATION AND USE OF THE SCREENING METHOD FOR VACCINE EFFICACY EVALUATION

      Revue d'epidemiologie et de sante publique
    54. LEPONT F; VALLERON AJ; SPIRA A; BAJOS N; BEJIN A; BELTZER N; BOZON M; DUCOT B; DURANDEAU A; FERRAND A; GIAMI A; GILLOIRE A; GIRAUD M; LERIDON H; MESSIAH A; LUDWIG D; MOATTI JP; MOUNNIER L; OLOMUCKI H; POPLAVSKY J; RIANDEY B; SPENCER B; SZTALRYD JM; TOUZARD H
      POTENTIAL HIV EPIDEMIC ASSOCIATED WITH HETEROSEXUAL TRANSMISSION AMONG YOUTH IN FRANCE

      AIDS
    55. ROUZIOUX C; COSTAGLIOLA D; BURGARD M; BLANCHE S; MAYAUX MJ; GRISCELLI C; VALLERON AJ
      TIMING OF MOTHER-TO-CHILD HIV-1 TRANSMISSION DEPENDS ON MATERNAL STATUS

      AIDS
    56. RUDE N; COSTAGLIOLA D; VALLERON AJ
      CUMULATIVE INCIDENCE OF HIV-INFECTION AND AIDS CASE PREDICTION IN FRANCE

      Lancet


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 15:57:37